Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175

Shortened current direct-acting antiviral (DAA) therapies while less expensive, have not provided satisfactory efficacy in naïve cirrhotics, treatment experienced non-cirrhotics or even genotype-3 (GT3)-infected patients. Since DAA regimens consist of the same classes of inhibitors—NS5A (NS5Ai) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallay, Philippe A., Chatterji, Udayan, Bobardt, Michael D., Long, Zhengyu, Zhang, Shengli, Su, Zhuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841536/
https://www.ncbi.nlm.nih.gov/pubmed/27104614
http://dx.doi.org/10.1371/journal.pone.0152036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841536/
https://www.ncbi.nlm.nih.gov/pubmed/27104614
http://dx.doi.org/10.1371/journal.pone.0152036

Ejemplares similares